Masimo (MASI)

• Market cap: $9.04B
• 1 day: -4.09%
• 5 days: -5.85%
• 1 month: -3.47%
• 3 months: 0.50%
• 6 months: 37.79%
• Year to date: 0.82%
• 1 year: 28.67%
• 5 years: -4.71%
• 10 years: 457.25%
• Sector: Healthcare
• Industry: Electromedical & Electrotherapeutic Apparatus

About: Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.

Employees: 3,796

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

70% more call options, than puts

Call options by funds: $21.3M | Put options by funds: $12.6M

33% more funds holding in top 10

Funds holding in top 10: 3 [Q3] → 4 (+1) [Q4]

27% more capital invested

Capital invested by funds: $6.7B [Q3] → $8.54B (+$1.84B) [Q4]

25% more first-time investments, than exits

New positions opened: 60 | Existing positions closed: 48

1.39% more ownership

Funds ownership: 94.61% [Q3] → 96.0% (+1.39%) [Q4]

1% more repeat investments, than reductions

Existing positions increased: 114 | Existing positions reduced: 113

1% less funds holding

Funds holding: 355 [Q3] → 353 (-2) [Q4]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $190 12% upside
• Avg. target: $197 16% upside
• High target: $210 24% upside

4 analyst ratings

• positive: 4 100%
• neutral: 0 0%
• negative: 0 0%

Raymond James Jayson Bedford 80% 1-year accuracy 20 / 25 met price target	14% upside $194	Outperform Maintained	27 Dec 2024
Piper Sandler Jason Bednar 45% 1-year accuracy 17 / 38 met price target	24% upside $210	Overweight Maintained	18 Dec 2024
Wells Fargo Vik Chopra 83% 1-year accuracy 10 / 12 met price target	14% upside $193	Overweight Maintained	11 Dec 2024
Stifel Rick Wise 64% 1-year accuracy 21 / 33 met price target	12% upside $190	Buy Reiterated	22 Nov 2024